GlycoCheck™ Related Research:
Diabetes/Obesity
-
Effects of Glucagon-Like Peptide-1 Receptor Agonists, Sodium-Glucose Cotransporter-2 Inhibitors, and Their Combination on Endothelial Glycocalyx, Arterial Function, and Myocardial Work Index in Patients With Type 2 Diabetes Mellitus After 12-Month Treatment.
Ikonomidis I, Pavlidis G, Thymis J, Birba D, Kalogeris A, Kousathana F, Kountouri A, Balampanis K, Parissis J, Andreadou I, Katogiannis K, Dimitriadis G, Bamias A, Iliodromitis E, Lambadiari V.J Am Heart Assoc. 2020 May 5;9(9):e015716.
-
P673 Improvement of arterial stiffness and myocardial deformation in patients with poorly controlled diabetes mellitus type 2 after optimization of antidiabetic medication.
Lambadiari V, Pavlidis G, Kousathana F, Maratou E, Georgiou D, Andreadou I, Kountouri A, Varoudi M, Balampanis K, Parissis J, Triantafyllidi H, Katogiannis K, Birba D, Lekakis J, Dimitriadis G, Ikonomidis I.J Clin Med. 2019 Jul 5;8(7):983.
-
Endothelial Dysfunction Is Associated with Decreased Nitric Oxide Bioavailability in Dysglycaemic Subjects and First-Degree Relatives of Type 2 Diabetic Patients.
Ignatios Ikonomidis, George Pavlidis, Maria Tsoumani, Foteini Kousathana, Konstantinos Katogiannis, Damianos Tsilivarakis, John Thymis, Aikaterini Kountouri, Emmanouil Korakas,, Loukia Pliouta, Athanasios Raptis, John Parissis, Ioanna Andreadou, Vaia Lambadiari J Clin Med. 2022 Jun 9;11(12):3299.
-
Role of dietary interventions on microvascular health in South-Asian Surinamese people with type 2 diabetes in the Netherlands: A randomized controlled trial.
van der Velden AIM, IJpelaar DHT, Chandie Shaw PK, Pijl H, Vink H, van der Vlag J, Rabelink TJ, van den Berg BM.Nutr Diabetes. 2024 Apr 10;14(1):17.
-
Microascular differences in individuals with obesity at risk of deveoping cardiovascular disease.
van der Velden AIM, van den Berg BM, de Mutsert R, van der Vlag J, Jukema JW, Rosendaal FR, Rabelink TJ, Vink H.Obesity (Silver Spring). 2021 Sep;29(9):1439-1444.
-
Endothelial glycocalyx and cardio-renal risk factors in type 1 diabetes.
Stougaard EB, Winther SA, Amadid H, Frimodt-Møller M, Persson F, Hansen TW, Rossing P.PLoS One. 2021 Jul 30;16(7):e0254859.
-
Effects of Different Antidiabetic Medications on Endothelial Glycocalyx, Myocardial Function, and Vascular Function in Type 2 Diabetic Patients: One Year Follow-Up Study.
Lambadiari V, Pavlidis G, Kousathana F, Maratou E, Georgiou D, Andreadou I, Kountouri A, Varoudi M, Balampanis K, Parissis J, Triantafyllidi H, Katogiannis K, Birba D, Lekakis J, Dimitriadis G, Ikonomidis I.J Clin Med. 2019 Jul 5;8(7):983.
-
Early detection of left ventricular dysfunction in first-degree relatives of diabetic patients by myocardial deformation imaging: The role of endothelial glycocalyx damage
Ikonomidis I, Pavlidis G, Lambadiari V, Kousathana F, Varoudi M, Spanoudi F, Maratou E, Parissis J, Triantafyllidi H, Dimitriadis G, Lekakis J.Int J Cardiol. 2017 Apr 15;233:105-112.
-
Skeletal muscle capillary density and microvascular function are compromised with aging and type 2 diabetes.
Groen BB, Hamer HM, Snijders T, van Kranenburg J, Frijns D, Vink H, van Loon LJ.J Appl Physiol (1985). 2014 Apr 15;116(8):998-1005.
-
Sublingual microvasculature in diabetic patients.
Wadowski PP, Kautzky-Willer A, Gremmel T, Koppensteiner R, Wolf P, Ertl S, Weikert C, Schörgenhofer C, Jilma B.Microvasc Res. 2020 May;129:103971.
-
Early impairment of skeletal muscle endothelial glycocalyx barrier properties in diet-induced obesity in mice.
Eskens BJ, Leurgans TM, Vink H, Vanteeffelen JW.Physiol Rep. 2014 Jan 6;2(1):e00194.